Department of Psychology, The Beckman Institute, 405 N Mathews Avenue, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Neuroscience. 2013 Feb 12;231:125-35. doi: 10.1016/j.neuroscience.2012.11.028. Epub 2012 Nov 20.
Adderall is widely prescribed for attention deficit hyperactivity disorder (ADHD) though long term neurological effects of the main ingredient d-amphetamine are not well understood. The purpose of this study was to examine effects of clinically prescribed doses of d-amphetamine and one abuse dose administered from childhood to adulthood on adult hippocampal neurogenesis and activation of the granule layer of the dentate gyrus. Beginning in early adolescence (age 28 days) to adulthood (age 71), male C57BL/6J mice were administered twice daily i.p. injections of vehicle, 0.25, 0.5 or 2mg/kg d-amphetamine. Locomotor activity was measured in home cages by video tracking. At age 53-56, mice received bromodeoxyuridine (BrdU) injections to label dividing cells. Immunohistochemical detection of BrdU, neuronal nuclear protein (NeuN), doublecortin (DCX) and Ki67 was used to measure neurogenesis and cell proliferation at age 71. ΔFosB was measured as an indicator of repeated neuronal activation. An additional cohort of mice was treated similarly except euthanized at age 58 to measure activation of granule neurons from d-amphetamine (by detection of c-Fos) and cell proliferation (Ki67) at a time when the fate of BrdU cells would have been determined in the first cohort. d-Amphetamine dose-dependently increased survival and differentiation of BrdU cells into neurons and increased number of DCX cells without affecting the number of Ki67 cells. Low doses of d-amphetamine decreased c-Fos and ΔFosB in the granule layer. Only the high dose induced substantial locomotor stimulation and sensitization. Results suggest both therapeutic and abuse doses of d-amphetamine increase the number of new neurons in the hippocampus when administered from adolescence to adulthood by increasing survival and differentiation of cells into neurons not by increasing progenitor cell proliferation. Mechanisms for amphetamine-induced neurogenesis are unknown but appear activity independent. Results suggest part of the beneficial effects of therapeutic doses of d-amphetamine for ADHD could be via increased hippocampal neurogenesis.
阿得拉(Adderall)被广泛用于治疗注意力缺陷多动障碍(ADHD),尽管其主要成分 d-苯丙胺的长期神经效应尚不清楚。本研究的目的是检查临床规定剂量的 d-苯丙胺和从儿童期到成年期给药的一种滥用剂量对成年海马神经发生和齿状回颗粒层的激活的影响。从青春期早期(28 天大)到成年期(71 岁),雄性 C57BL/6J 小鼠每天两次接受腹腔注射载体、0.25、0.5 或 2mg/kg d-苯丙胺。通过视频跟踪在家用笼子中测量运动活动。在 53-56 岁时,小鼠接受溴脱氧尿苷(BrdU)注射以标记分裂细胞。免疫组织化学检测 BrdU、神经元核蛋白(NeuN)、双皮质素(DCX)和 Ki67 用于测量 71 岁时的神经发生和细胞增殖。ΔFosB 被测量为重复神经元激活的指标。另一组小鼠接受类似的治疗,但在 58 岁时安乐死,以测量来自 d-苯丙胺的颗粒神经元的激活(通过检测 c-Fos)和细胞增殖(Ki67),此时第一组中的 BrdU 细胞的命运将被确定。d-苯丙胺剂量依赖性地增加 BrdU 细胞存活并分化为神经元,并增加 DCX 细胞的数量,而不影响 Ki67 细胞的数量。低剂量的 d-苯丙胺减少了颗粒层中的 c-Fos 和 ΔFosB。只有高剂量诱导了大量的运动刺激和敏化。结果表明,从青春期到成年期给予治疗和滥用剂量的 d-苯丙胺都可以通过增加细胞存活和分化为神经元而不是通过增加祖细胞增殖来增加海马中的新神经元数量。阿得拉诱导神经发生的机制尚不清楚,但似乎与活动无关。结果表明,治疗剂量的 d-苯丙胺对 ADHD 的部分有益作用可能是通过增加海马神经发生。